Evidence map›Paper›PMID 42093822›Full record

ArticleJournal of ophthalmology2026

Comparative Outcomes of Pars Plana Vitrectomy With and Without Adjunct Laser Photocoagulation in Optic Disc Pit Maculopathy.

Mehmet Sahin Sevim, Semra Sevim

Abstract read
In one paragraph

Article in Journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mehmet Sahin SevimDepartments of Ophthalmology, World Eye Hospital, Altunizade Branch, Istanbul, Turkey.ORCID https://orcid.org/0000-0002-9518-9912
Semra SevimDepartments of Ophthalmology, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey, haydarpasanumune.gov.tr.ORCID https://orcid.org/0009-0002-1747-5427

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Optic disc pit maculopathy (ODP-M) is a rare condition that can lead to progressive visual impairment. Although pars plana vitrectomy (PPV) has become the mainstay of treatment, the additional benefit of adjunct peripapillary laser photocoagulation remains controversial. We hypothesized that adjunct laser photocoagulation does not provide additional anatomical or functional benefit when combined with PPV and gas tamponade. This study aimed to compare the anatomical and functional outcomes of PPV with and without adjunct peripapillary endolaser photocoagulation in the management of ODP-M. Methods: This retrospective comparative study included 19 eyes of 17 patients who underwent PPV with gas tamponade for ODP-M between January 2013 and August 2024. Patients were divided into two groups according to whether endolaser photocoagulation was applied to the temporal margin of the optic disc during surgery. Pre- and postoperative best-corrected visual acuity (BCVA), central retinal thickness (CRT), and anatomical outcomes were compared between groups. Anatomical success was defined as complete resolution of subretinal and/or intraretinal fluid on spectral-domain optical coherence tomography (SD-OCT). Results: The mean postoperative follow-up duration was 20 months (range, 12-36 months). Anatomical success was achieved in 9 of 10 eyes (90%) in the laser group and 8 of 9 eyes (89%) in the nonlaser group ( Conclusion: PPV with gas tamponade provides favorable anatomical and functional outcomes in ODP-M. The addition of endolaser photocoagulation does not yield further benefit and may be unnecessary in standard PPV-based management.

Indexed as

anatomical successendolaser photocoagulationgas tamponadeoptic disc pit maculopathypars plana vitrectomy

Identifiers

PMID42093822
PMCPMC13139903

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.